ACLY inhibition promotes tumour immunity and suppresses liver cancer

shared a link to vibe with.

2025-07-30 21:20:24 -

WWW.NATURE.COM

Nature, Published online: 30 July 2025; doi:10.1038/s41586-025-09297-0Using metabolic dysfunction-associated steatohepatitis-driven hepatocellular carcinoma mouse models, an ATP citrate lyase inhibitor reduces tumour burden and enhances efficacy of current standards of care.

0 Commentarios 0 Acciones 69 Views 0 Vista previa